Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R KUBIN

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Infection|November 1, 1993
Safety and efficacy of ciprofloxacin in paediatric patients--reviewR Kubin
International Archives of Allergy and Immunology|January 1, 1992
Intratracheal application of Sephadex in rats leads to massive pulmonary eosinophilia without bronchial hyperreactivity to acetylcholineR Kubin, U Deschl, M Linssen, et al.
International Journal of Clinical Practice|October 12, 2001
The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis: a Spanish physician and patient experienceM Miravitlles, F Ros, A Cobos, et al.
The Journal of International Medical Research|June 8, 2001
Clinical experience in Germany of treating community-acquired respiratory infections with the new 8-methoxyfluoroquinolone, moxifloxacinH Landen, M Möller, G S Tillotson, et al.
The Journal of International Medical Research|July 10, 1999
Oral ciprofloxacin in the treatment of pseudomonas exacerbations of paediatric cystic fibrosis: clinical efficacy and safety evaluation using magnetic resonance image scanningA Redmond, L Sweeney, M MacFarland, et al.
Respiratory Medicine|August 28, 1999
The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitisR C Read, A Kuss, F Berrisoul, et al.
The European Respiratory Journal|February 7, 2003
Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumoniaA Torres, J F Muir, P Corris, et al.
The Journal of International Medical Research|June 8, 2001
Treatment outcomes in acute exacerbations of chronic bronchitis: comparison of macrolides and moxifloxacin from the patient perspectiveJ Lorenz, I M Thate-Waschke, O Mast, et al.
The Journal of Antimicrobial Chemotherapy|December 10, 1999
Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitisR Wilson, R Kubin, I Ballin, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatmentR Finch, D Schürmann, O Collins, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Infection|November 1, 1993
Safety and efficacy of ciprofloxacin in paediatric patients--reviewR Kubin
International Archives of Allergy and Immunology|January 1, 1992
Intratracheal application of Sephadex in rats leads to massive pulmonary eosinophilia without bronchial hyperreactivity to acetylcholineR Kubin, U Deschl, M Linssen, et al.
International Journal of Clinical Practice|October 12, 2001
The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis: a Spanish physician and patient experienceM Miravitlles, F Ros, A Cobos, et al.
The Journal of International Medical Research|June 8, 2001
Clinical experience in Germany of treating community-acquired respiratory infections with the new 8-methoxyfluoroquinolone, moxifloxacinH Landen, M Möller, G S Tillotson, et al.
The Journal of International Medical Research|July 10, 1999
Oral ciprofloxacin in the treatment of pseudomonas exacerbations of paediatric cystic fibrosis: clinical efficacy and safety evaluation using magnetic resonance image scanningA Redmond, L Sweeney, M MacFarland, et al.
Respiratory Medicine|August 28, 1999
The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitisR C Read, A Kuss, F Berrisoul, et al.
The European Respiratory Journal|February 7, 2003
Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumoniaA Torres, J F Muir, P Corris, et al.
The Journal of International Medical Research|June 8, 2001
Treatment outcomes in acute exacerbations of chronic bronchitis: comparison of macrolides and moxifloxacin from the patient perspectiveJ Lorenz, I M Thate-Waschke, O Mast, et al.
The Journal of Antimicrobial Chemotherapy|December 10, 1999
Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitisR Wilson, R Kubin, I Ballin, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatmentR Finch, D Schürmann, O Collins, et al.
Pageof 1